Full name
"ANIMAL PHARMA ŻUROMIN - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA
uses securityreCAPTCHA
"ANIMAL PHARMA ŻUROMIN - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA
UL. DĄBROWSZCZAKÓW 39, 10-542 OLSZTYN
TAX ID7393659158
Rate company:
"ANIMAL PHARMA ŻUROMIN - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA
TAX ID7393659158
KRS0000289986
address
UL. DĄBROWSZCZAKÓW 39, 10-542 OLSZTYN
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7393659158
REGON
280255540
KRS
0000289986
Legal form
general partnership
Register Address
UL. DĄBROWSZCZAKÓW 39, 10-542 OLSZTYN
Date of registration in KRS
2007-10-04
Date of commencement of economic activity
2007-10-04
Act signature
OL.VIII NS-REJ.KRS/3117/25/459/ADE
Pkd codes
75.00.Z - Veterinary activities
70.22.Z - Head office activities and management consultancy
72.19.Z - Scientific research and development activities
73.12.D - Advertising through mass media
73.20.Z - Market research and public opinion polling
96.09.Z - Individual service activities
Payer VAT status
Active
Vat list bank account(s)
PL96 2490 0005 0000 4612 8910 9201 
PL50 2490 0005 0000 4600 7784 9010 PL44 2490 0005 0000 4600 3124 1976 PL09 2490 0005 0000 4530 9738 0451 Show more bank accounts from VAT list (1)
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | 4,8 | 5,1 | 8,6 | 70,6 |
Gross profit (loss) | 4,8 | 5,3 | 8,8 | 66,6 |
EBITDA | 4,8 | 5,2 | 8,7 | 67,2 |
Short time liabilities | 7,9 | 6,3 | 6,7 | 6,4 |
Other operating costs | 0 | 0 | 0 | 4330,9 |
Equity capital | 4,8 | 5,3 | 8,8 | 66,4 |
Operating profit (EBIT) | 4,8 | 5,2 | 8,7 | 67,5 |
Assets | 12,8 | 11,6 | 15,5 | 33,8 |
Net profit (loss) | 4,8 | 5,3 | 8,8 | 66,6 |
Cash | 3,4 | 1,5 | 1,5 | -0,5 |
Net income from sale | 21,5 | 27,1 | 38,5 | 42,1 |
Liabilities and provisions for liabilities | 7,9 | 6,3 | 6,7 | 6,4 |
Working assets | 11,5 | 10,5 | 14,6 | 39 |
Other income costs | 0 | 0,1 | 0,1 | -44,3 |
Depreciation | 0 | 0 | 0,1 | 37,2 |
% | % | % | p.p. | |
Profitability of capital | 99,7 | 99,7 | 99,8 | 0,1 |
Equity capital to total assets | 37,9 | 45,7 | 56,8 | 11,1 |
Gross profit margin | 22,4 | 19,4 | 22,8 | 3,4 |
EBITDA Margin | 22,3 | 19,3 | 22,7 | 3,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 134 | 85 | 63 | -22 |
Current financial liquidity indicator | 1.452868103981018 | 1.6746721267700195 | 2.1876699924468994 | 0,5 |
Net dept to EBITDA | -0.7068800926208496 | -0.28928297758102417 | -0.17216479778289795 | 0,1 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download docx01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.